These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 27339902)
1. An efficient strategy to enhance binding affinity and specificity of a known isozyme inhibitor. Jee JE; Lim J; Ong YS; Oon J; Gao L; Choi HS; Lee SS Org Biomol Chem; 2016 Jul; 14(28):6833-9. PubMed ID: 27339902 [TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II. Di Fiore A; De Simone G; Menchise V; Pedone C; Casini A; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2005 Apr; 15(7):1937-42. PubMed ID: 15780637 [TBL] [Abstract][Full Text] [Related]
3. 4-Substituted-2,3,5,6-tetrafluorobenzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, XII, and XIII. Dudutienė V; Zubrienė A; Smirnov A; Gylytė J; Timm D; Manakova E; Gražulis S; Matulis D Bioorg Med Chem; 2013 Apr; 21(7):2093-106. PubMed ID: 23394791 [TBL] [Abstract][Full Text] [Related]
4. Design of [(2-pyrimidinylthio)acetyl]benzenesulfonamides as inhibitors of human carbonic anhydrases. Čapkauskaitė E; Zubrienė A; Baranauskienė L; Tamulaitienė G; Manakova E; Kairys V; Gražulis S; Tumkevičius S; Matulis D Eur J Med Chem; 2012 May; 51():259-70. PubMed ID: 22440859 [TBL] [Abstract][Full Text] [Related]
5. Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies. Eldehna WM; Al-Ansary GH; Bua S; Nocentini A; Gratteri P; Altoukhy A; Ghabbour H; Ahmed HY; Supuran CT Eur J Med Chem; 2017 Feb; 127():521-530. PubMed ID: 28109946 [TBL] [Abstract][Full Text] [Related]
6. Hydroxylamine-O-sulfonamide is a versatile lead compound for the development of carbonic anhydrase inhibitors. Di Fiore A; Vergara A; Caterino M; Alterio V; Monti SM; Ombouma J; Dumy P; Vullo D; Supuran CT; Winum JY; De Simone G Chem Commun (Camb); 2015 Jul; 51(57):11519-22. PubMed ID: 26094945 [TBL] [Abstract][Full Text] [Related]
7. Designing of novel carbonic anhydrase inhibitors and activators. Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):49-68. PubMed ID: 15328829 [TBL] [Abstract][Full Text] [Related]
8. Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX. Thiry A; Ledecq M; Cecchi A; Dogné JM; Wouters J; Supuran CT; Masereel B J Med Chem; 2006 May; 49(9):2743-9. PubMed ID: 16640335 [TBL] [Abstract][Full Text] [Related]
9. Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors. Rosatelli E; Carotti A; Ceruso M; Supuran CT; Gioiello A Bioorg Med Chem Lett; 2014 Aug; 24(15):3422-5. PubMed ID: 24948563 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity. Congiu C; Onnis V; Deplano A; Balboni G; Dedeoglu N; Supuran CT Bioorg Med Chem Lett; 2015 Sep; 25(18):3850-3. PubMed ID: 26233435 [TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes. Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204 [TBL] [Abstract][Full Text] [Related]
12. Pseudodynamic combinatorial libraries: a receptor-assisted approach for drug discovery. Corbett AD; Cheeseman JD; Kazlauskas RJ; Gleason JL Angew Chem Int Ed Engl; 2004 Apr; 43(18):2432-6. PubMed ID: 15114583 [No Abstract] [Full Text] [Related]
13. New hydroxypyrimidinone-containing sulfonamides as carbonic anhydrase inhibitors also acting as MMP inhibitors. Esteves MA; Ortet O; Capelo A; Supuran CT; Marques SM; Santos MA Bioorg Med Chem Lett; 2010 Jun; 20(12):3623-7. PubMed ID: 20478708 [TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides. Cecchi A; Taylor SD; Liu Y; Hill B; Vullo D; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2005 Dec; 15(23):5192-6. PubMed ID: 16203142 [TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX. Pastorekova S; Casini A; Scozzafava A; Vullo D; Pastorek J; Supuran CT Bioorg Med Chem Lett; 2004 Feb; 14(4):869-73. PubMed ID: 15012984 [TBL] [Abstract][Full Text] [Related]
16. Structure-Activity Relationships of Benzenesulfonamide-Based Inhibitors towards Carbonic Anhydrase Isoform Specificity. Bhatt A; Mahon BP; Cruzeiro VW; Cornelio B; Laronze-Cochard M; Ceruso M; Sapi J; Rance GA; Khlobystov AN; Fontana A; Roitberg A; Supuran CT; McKenna R Chembiochem; 2017 Jan; 18(2):213-222. PubMed ID: 27860128 [TBL] [Abstract][Full Text] [Related]
17. Benzenesulfonamides with pyrimidine moiety as inhibitors of human carbonic anhydrases I, II, VI, VII, XII, and XIII. Čapkauskaitė E; Zubrienė A; Smirnov A; Torresan J; Kišonaitė M; Kazokaitė J; Gylytė J; Michailovienė V; Jogaitė V; Manakova E; Gražulis S; Tumkevičius S; Matulis D Bioorg Med Chem; 2013 Nov; 21(22):6937-47. PubMed ID: 24103428 [TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties. Ghorab MM; Alsaid MS; Ceruso M; Nissan YM; Supuran CT Bioorg Med Chem; 2014 Jul; 22(14):3684-95. PubMed ID: 24878360 [TBL] [Abstract][Full Text] [Related]
19. S-glycosyl primary sulfonamides--a new structural class for selective inhibition of cancer-associated carbonic anhydrases. Lopez M; Paul B; Hofmann A; Morizzi J; Wu QK; Charman SA; Innocenti A; Vullo D; Supuran CT; Poulsen SA J Med Chem; 2009 Oct; 52(20):6421-32. PubMed ID: 19827837 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of sulfonamides with effective inhibitory action against Porphyromonas gingivalis γ-carbonic anhydrase. Ceruso M; Del Prete S; AlOthman Z; Osman SM; Scozzafava A; Capasso C; Supuran CT Bioorg Med Chem Lett; 2014 Aug; 24(16):4006-10. PubMed ID: 25011913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]